All fatigue treatment cohorts displayed similar trajectories of average monthly work loss, shifting from an increasing trend before treatment initiation to no change after treatment initiation.
← all excerpts
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.
1
—
—